GL1X · GenesisL1 explorer

MolNFT v1 · #170071 · protein

Crystal structure of the kdr (VEGFR2) kinase domain in complex with a type-II inhibitor bearing an acrylamide

6XVK: “Crystal structure of the kdr (VEGFR2) kinase domain in complex with a type-II inhibitor bearing an acrylamide”. X-ray diffraction, 1 ligand (O3E). MolNFT v1 #170071 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6XVK
Type
protein
Length
298 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P35968
Ligands
O3E

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein298—P35968

Ligands and binding sites

  • O3E · ~{N}-(4,4-dimethyl-2-prop-1-ynyl-3,1-benzoxazin-6-yl)-2-[3-methoxy-5-(7-methoxyquinolin-4-yl)oxy-pyridin-2-yl]ethanamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6XVK · Crystal structure of the KDR (VEGFR2) kinase domain in complex with a type-II inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.